High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting.

about

High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting.

Item

http://www.wikidata.org/entity/Q41994113

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

High rate of serious infection ...... herapy in a real-life setting.

@en

type

Item

label

High rate of serious infection ...... herapy in a real-life setting.

@en

prefLabel

High rate of serious infection ...... herapy in a real-life setting.

@en

P1476

High rate of serious infection ...... therapy in a real-life setting

@en

P2093

Adriana Maluf Elias Sallum

http://www.w3.org/2001/XMLSchema#string

Ana Renata Schmidt

http://www.w3.org/2001/XMLSchema#string

Claudia Goldenstein-Schainberg

http://www.w3.org/2001/XMLSchema#string

Clovis A Silva

http://www.w3.org/2001/XMLSchema#string

Juliana Barbosa Brunelli

http://www.w3.org/2001/XMLSchema#string

Nádia Emi Aikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis.

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.

A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors.

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.

The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.

Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan.

P304

264-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14397595.2017.1349059

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eloisa Bonfa

P577

2017-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28949278

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis